0.45Open0.40Pre Close155 Volume50 Open Interest79.00Strike Price4.26KTurnover42.10%IV0.77%PremiumDec 13, 2024Expiry Date0.19Intrinsic Value100Multiplier1DDays to Expiry0.61Extrinsic Value100Contract SizeAmericanOptions Type-0.5096Delta0.2294Gamma98.51Leverage Ratio-0.3513Theta-0.0011Rho-50.20Eff Leverage0.0165Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet